Blood Clotting Problems

This means your body isn't making or using the proteins needed to stop bleeding properly. This can lead to easy bruising or bleeding, or sometimes, blood clots forming where they shouldn't. It's like the body's natural 'stop the bleeding' system is faulty.

Condition

What people with Blood Clotting Problems report

Every report comes from a Lived member, sent anonymously.

Have you tried Factor VIII for Blood Clotting Problems?

NameHow it went

About Blood Clotting Problems

What It Is

Blood clotting problems are conditions in which the proteins that control clotting, called clotting factors or coagulation factors, are missing, low or not working as they should. Healthy clotting is a balance. Some proteins help a clot form to seal an injured blood vessel, while others keep clots from forming where they are not needed. When that balance tips, the problem can go in either direction. When blood does not clot enough, the result is a bleeding disorder. People may bruise easily, have frequent or hard-to-stop nosebleeds, bleed heavily after dental work, surgery or childbirth, or have very heavy menstrual periods. Von Willebrand disease is the most common inherited bleeding disorder, and hemophilia, caused by low levels of factor VIII or factor IX, is the best known. In severe forms, bleeding can start without an obvious injury, including inside joints and muscles. When blood clots too easily, the result is a clotting disorder, also called thrombophilia. Clots can form inside veins without an injury, most often as a deep vein thrombosis (a clot in a deep vein, usually in the leg) or a pulmonary embolism (a clot that travels to the lungs). A clotting disorder raises the lifetime chance of a clot, but many people who have one never develop a clot.

Causes & Risk Factors

Some clotting problems are inherited. A change in the gene that carries the instructions for a clotting protein can mean the protein is made incorrectly or not at all. The genes for hemophilia A and B sit on the X chromosome, so hemophilia mostly affects males, although females who carry the gene change can still have bleeding problems, such as heavy periods or bleeding after childbirth. On the clotting side, the most common inherited changes are factor V Leiden, found in about 5% of people of European descent, and the prothrombin gene change, found in about 2% of people of European descent. These common changes are less likely to cause serious clots than rarer inherited shortages of the body's natural anticlotting proteins (protein C, protein S and antithrombin). Many clotting problems are acquired, meaning they develop during life, and acquired bleeding problems are more common than inherited ones. Severe liver disease reduces the clotting factors the liver makes, and a lack of vitamin K impairs several of them, which is why newborns receive a vitamin K shot at birth. Blood-thinning medicines reduce clotting on purpose. Less often, the immune system makes antibodies that block a clotting factor, as in acquired hemophilia, which is more common in older adults and during and after pregnancy. The most common acquired clotting disorder is antiphospholipid syndrome, an autoimmune condition in which antibodies raise the risk of clots. For someone with an inherited tendency to clot, other factors often explain why a clot appears at a particular time: surgery, long periods without moving, pregnancy and the weeks after birth, estrogen-containing birth control or menopause hormone therapy, cancer and smoking.

How It's Diagnosed

Diagnosis begins with a careful history: how easily someone bruises or bleeds and for how long, bleeding after dental work, surgery or childbirth, how heavy menstrual periods are, any past clots or miscarriages, relatives with bleeding or clotting problems, and every medicine taken, including aspirin and other over-the-counter products. Blood tests then narrow down the cause. A complete blood count checks the number of platelets (the small blood cells that form the first plug at an injury), because a low count points to a platelet problem rather than a clotting-protein problem. The prothrombin time (PT) and partial thromboplastin time (PTT, also called aPTT) measure how long a blood sample takes to clot. Each one tests a different group of clotting factors, so which one is prolonged tells the clinician where to look next. A mixing test helps tell a missing factor apart from an antibody that is blocking one. Specific factor tests then measure the level or activity of individual proteins, such as factor VIII for hemophilia A or von Willebrand factor for von Willebrand disease. In hemophilia, the factor level also sets severity: the lower the level, the more likely bleeding is to happen without an injury. Genetic testing can confirm an inherited cause and inform relatives. Testing for an inherited tendency to clot is used more selectively than many people expect. After a typical clot, current guidance does not recommend routine thrombophilia testing, because in most cases the result does not change which blood thinner is used or how it is monitored. Testing is more useful when a result could change decisions, such as for people with a strong family history of the rarer, higher-risk deficiencies. Some medicines can affect these results, and a hematologist (a doctor who specializes in blood disorders) often guides the testing.

Treatment Options

Treatment depends on which side of the balance is affected, which protein is involved and how severe the problem is. Some people with a mild disorder need treatment only around surgery, dental work or childbirth. Inherited clotting problems generally cannot be cured, but they are treatable, and care is often led by a hematologist. People with hemophilia and other inherited bleeding disorders are commonly followed at a hemophilia treatment center, where nurses, physical therapists and social workers work alongside the doctors. For bleeding disorders, the core approach is to replace or stand in for the missing factor. Factor replacement therapy, made in a lab or purified from donated blood, is given into a vein either when a bleed happens or on a regular schedule to prevent bleeds, called prophylaxis. Regular prophylaxis is used for severe hemophilia because it lowers the chance of bleeding and the joint damage repeated bleeds cause. Its main trade-off is that some people develop inhibitors, antibodies that block the replacement factor and make bleeding harder to treat, so blood tests check for them. Emicizumab (Hemlibra) is an antibody medicine, injected under the skin, that does the job of factor VIII and is used to prevent bleeds in hemophilia A, including in people with inhibitors. A one-time gene therapy, etranacogene dezaparvovec (Hemgenix), is approved in the US for some adults with hemophilia B; it delivers a working factor IX gene to the liver so the body can make its own factor IX, which can reduce or replace regular factor infusions. Other medicines help with milder bleeding. Desmopressin (DDAVP), a man-made hormone that releases the body's stored factor VIII and von Willebrand factor, can help stop minor bleeding in milder forms of von Willebrand disease and hemophilia A. It does not work for hemophilia B. Tranexamic acid, which keeps a clot from breaking down too soon, helps with bleeding during dental work and other procedures and after childbirth, and hormonal birth control can lighten heavy periods in von Willebrand disease. Acquired problems are treated at their cause: vitamin K for vitamin K deficiency, plasma containing all the clotting factors for bleeding linked to liver disease, and, in acquired hemophilia, medicines to control bleeding plus immune-suppressing medicines to stop the antibodies. For clotting disorders, many people never have a clot and need no daily treatment; the plan instead covers higher-risk times, such as blood thinners after surgery. After a clot, blood thinners (anticoagulants) keep it from growing and prevent new ones. Warfarin is a pill that needs frequent blood tests to keep the dose in the right range, heparin is given as a shot, and direct oral anticoagulants such as apixaban (Eliquis) do not need routine blood monitoring. For antiphospholipid syndrome, warfarin is usually preferred, because the newer pills have worked less well at preventing repeat clots. The central trade-off of any blood thinner is a higher chance of bleeding. How long treatment continues depends mainly on what triggered the clot and whether clots have come back, rather than on the inherited test result alone.

What to Expect

Inherited clotting problems are lifelong, but daily life varies widely. Many people with mild von Willebrand disease, a mild factor deficiency or factor V Leiden have few or no symptoms and mainly need a plan for surgery, dental work, pregnancy and new medicines. People with severe hemophilia need ongoing treatment, and with it most lead a fairly normal life. Repeated bleeding into joints over years can cause pain and joint damage, which is why prevention, physical therapy and regular checkups at a treatment center matter. Treatment plans are adjusted over time, and regular blood tests check that treatment is still working. Some practical habits become routine. With a bleeding disorder, that means telling every dentist, surgeon and new prescriber about the condition, checking before taking aspirin or other pain relievers such as ibuprofen (both raise bleeding risk), wearing a medical ID, and staying active with guidance on lowering the risk of injury. Women with bleeding disorders, and carriers of hemophilia, benefit from planning pregnancy and delivery with their hematology team, since bleeding after childbirth is a particular risk. With a clotting disorder, the focus is on the situations that add risk. Estrogen-containing birth control and menopause hormone therapy raise the chance of a clot, so the choice of contraception or hormone therapy is worth discussing. Staying active, not smoking, getting up and moving on long trips, and planning ahead for surgery and pregnancy all help. People taking blood thinners have regular follow-up to balance preventing clots against the risk of bleeding. For families, genetic counseling can explain the chance of passing an inherited disorder to children and whether testing relatives would change anything for them.

When to Seek Help

Arrange an evaluation if you bruise easily, have frequent or long nosebleeds, bleed heavily after dental work, surgery or childbirth, or have periods that often last longer than seven days or need a new pad or tampon more than every hour. If a close relative has a bleeding or clotting disorder, ask about evaluation before planned surgery or pregnancy. If you already have a bleeding disorder, contact your hematology team or treatment center promptly for pain, swelling or stiffness in a joint or muscle, bleeding that does not stop with pressure, or blood in the urine or stool. If you have a clotting disorder or take a blood thinner, call your care team right away about a leg that becomes swollen, tender and painful, which can signal a deep vein clot. Call 911 or go to the emergency room for sudden shortness of breath, chest pain that worsens with a deep breath, coughing up blood, or fainting, which can mean a clot has reached the lungs. For someone with hemophilia or another significant bleeding disorder, a head injury or a sudden severe headache needs emergency care right away; tell the staff about the disorder at once, because clotting factor is usually given before any scan.

Questions to Ask Your Doctor

  1. 1.Is my problem with bleeding, clotting or both, and which protein is involved?
  2. 2.How severe is my condition, and what should happen before surgery, dental work or childbirth?
  3. 3.Should I be followed by a hematologist or at a hemophilia treatment center?
  4. 4.Which medicines, including pain relievers and hormonal birth control, should I avoid or discuss with you first?
  5. 5.Should my relatives be tested, and would the results change their care?

Last reviewed • Oct 2026

Educational content, not medical advice.